Epidemiology of Chilblains During the COVID-19 Pandemic
The incidence of chilblains increased during the COVID-19 pandemic, study data published in JAMA Dermatology demonstrates. This change may have…
The incidence of chilblains increased during the COVID-19 pandemic, study data published in JAMA Dermatology demonstrates. This change may have…
A recent study suggests that patients taking statin medications have a significantly lower risk for in-hospital death from COVID-19. The…
Although the clinical features of SARS-CoV-2 infection were first reported in 2019, it has also been established that hospitalized patients…
In the year since the global COVID-19 pandemic was declared in March 2020 by the World Health Organization,1 short-term treatments…
Among patients with coronavirus disease 2019 (COVID-19) who experience abdominal pain and diarrhea, there is a significant likelihood of Helicobacter…
Even before the COVID-19 pandemic began, concerning mental health trends and major treatment gaps were noted among adolescents in the…
Because of the novelty of the coronavirus that causes COVID-19, there is not enough evidence to determine whether antibodies produced…
The severe systemic inflammatory processes and hypercoagulability occurring with COVID-19 illness increase the risk for atherosclerotic plaque disruption and acute…
A probable drug interaction was observed in 2 patients taking warfarin who were initiated on remdesivir and dexamethasone for the…
Among professional athletes who have tested positive for coronavirus disease 2019 (COVID-19 infection 0.6% had imaging findings suggestive of inflammatory…